Contact Person : Joshua Lowth; Last Date for the submission of abstract : Not Available ; Description : An aging population and an increased understanding of CNS disorders is leading to many new drugs in development. With 90% failing clinical trials, the biggest barrier to commercial exploitation and the greatest cost is clinical development.